Share Price and Basic Stock Data
Last Updated: February 7, 2026, 3:34 pm
| PEG Ratio | -1.04 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Moongipa Capital Finance Ltd operates in the Non-Banking Financial Company (NBFC) sector, focusing on providing financial services. As of the latest reporting, the company’s stock price stood at ₹15.1, with a market capitalization of ₹13.9 Cr. The company reported a total revenue of ₹10.31 Cr for the trailing twelve months (TTM), an increase from ₹8.78 Cr in FY 2025. Revenue trends show a significant recovery with quarterly revenues peaking at ₹2.76 Cr in December 2023 and trending positively into 2024. However, historical quarterly revenue figures indicate volatility, with the lowest recorded revenue of ₹0.27 Cr in March 2023. This fluctuation highlights the company’s dependency on specific market conditions and potentially points to operational challenges in maintaining consistent revenue streams.
Profitability and Efficiency Metrics
Moongipa Capital Finance reported a net profit of ₹1.34 Cr, yielding a Return on Equity (ROE) of 9.43% and a Return on Capital Employed (ROCE) of 12.1%. These figures suggest a moderate profitability level relative to industry standards. The Interest Coverage Ratio (ICR) stood at an impressive 29.55x, indicating a strong ability to meet interest obligations, a critical metric for financial companies. However, the company’s operating profit margin (OPM) remains unreported, making it difficult to assess operational efficiency fully. The company’s financing margin percentage fluctuated, peaking at 44.23% in June 2023 but then declining, which could indicate challenges in managing financing costs or pricing strategies. The reliance on other income, which contributed marginally to overall profitability, emphasizes the need for Moongipa to diversify its revenue sources to bolster its bottom line.
Balance Sheet Strength and Financial Ratios
Moongipa Capital Finance’s balance sheet reflects a total asset base of ₹30.54 Cr as of March 2025, with reserves amounting to ₹15.21 Cr. The company has reported borrowings of ₹7.01 Cr, resulting in a debt-to-equity ratio of 0.30, indicating a conservative leverage position compared to typical sector ranges. The price-to-book value ratio stood at 0.77x, suggesting that the stock is undervalued relative to its book value. The current ratio of 4.29x and quick ratio of 3.29x demonstrate strong liquidity, providing a buffer against short-term financial obligations. However, the Cash Conversion Cycle (CCC) of 481.53 days indicates inefficiencies in converting investments in inventory and receivables into cash, highlighting a potential area for operational improvement.
Shareholding Pattern and Investor Confidence
As of December 2025, Moongipa Capital Finance had a shareholder base comprising 37.39% promoters and 62.61% public shareholders, reflecting a relatively balanced ownership structure. The number of shareholders increased to 5,686, showing growing investor interest. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) could indicate a lack of confidence from larger institutional players, which may affect the stock’s liquidity and perception in the market. The steady promoter holding suggests a commitment to the company’s long-term vision, which could instill confidence among retail investors. Nonetheless, the low institutional participation warrants attention as it may impact the stock’s stability and price movements, particularly in volatile market conditions.
Outlook, Risks, and Final Insight
Moongipa Capital Finance is positioned to leverage its strong interest coverage and liquidity metrics, which provide a solid foundation for future growth. However, the company faces several risks, including its high Cash Conversion Cycle, which could strain operational cash flows, and a lack of diversification in revenue streams. Additionally, the absence of institutional investors may hinder capital raising efforts in the future. To enhance its market position, Moongipa should focus on improving operational efficiencies and exploring new revenue-generating avenues. In the event of improved operational performance and an increase in institutional interest, the company could see a significant uplift in its market valuation and investor sentiment, but sustained volatility in revenue and profitability will remain a critical factor for potential investors to monitor.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.0 Cr. | 1.40 | 1.66/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 6.22 Cr. | 0.62 | 4.29/0.58 | 18.3 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 388 Cr. | 59.3 | 125/44.0 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.3 Cr. | 15.6 | 24.7/14.8 | 11.8 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 28.4 Cr. | 63.0 | 141/57.6 | 15.3 | 238 | 1.59 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,033.26 Cr | 390.21 | 71.10 | 514.75 | 0.23% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.60 | 0.27 | 1.04 | 2.62 | 2.76 | 3.02 | 3.31 | 2.32 | 2.16 | 1.10 | 3.10 | 3.95 | 2.94 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.17 | 0.16 | 0.16 |
| Expenses | 0.52 | 1.02 | 0.58 | 1.98 | 2.07 | 3.17 | 2.05 | 1.72 | 1.79 | 1.44 | 1.74 | 3.12 | 2.54 |
| Financing Profit | 0.08 | -0.75 | 0.46 | 0.64 | 0.69 | -0.15 | 1.26 | 0.60 | 0.37 | -0.41 | 1.19 | 0.67 | 0.24 |
| Financing Margin % | 13.33% | -277.78% | 44.23% | 24.43% | 25.00% | -4.97% | 38.07% | 25.86% | 17.13% | -37.27% | 38.39% | 16.96% | 8.16% |
| Other Income | 0.03 | 0.12 | 0.08 | 0.12 | 0.06 | 0.11 | 0.06 | 0.10 | 0.07 | 0.11 | 0.05 | 0.08 | 0.20 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Profit before tax | 0.09 | -0.65 | 0.53 | 0.74 | 0.73 | -0.06 | 1.31 | 0.69 | 0.43 | -0.31 | 1.22 | 0.73 | 0.42 |
| Tax % | 11.11% | -4.62% | 9.43% | 12.16% | 19.18% | -133.33% | 22.90% | 18.84% | 18.60% | 70.97% | 22.95% | 23.29% | 50.00% |
| Net Profit | 0.08 | -0.62 | 0.48 | 0.65 | 0.59 | 0.02 | 1.01 | 0.56 | 0.35 | -0.53 | 0.95 | 0.57 | 0.22 |
| EPS in Rs | 0.09 | -0.67 | 0.52 | 0.71 | 0.64 | 0.02 | 1.10 | 0.61 | 0.38 | -0.58 | 1.04 | 0.62 | 0.24 |
| Gross NPA % | |||||||||||||
| Net NPA % |
Last Updated: February 1, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for Moongipa Capital Finance Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Interest, as of Dec 2025, the value is 0.16 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.16 Cr..
- For Expenses, as of Dec 2025, the value is 2.54 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.12 Cr. (Sep 2025) to 2.54 Cr., marking a decrease of 0.58 Cr..
- For Other Income, as of Dec 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.08 Cr. (Sep 2025) to 0.20 Cr., marking an increase of 0.12 Cr..
- For Depreciation, as of Dec 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.02 Cr..
- For Profit before tax, as of Dec 2025, the value is 0.42 Cr.. The value appears to be declining and may need further review. It has decreased from 0.73 Cr. (Sep 2025) to 0.42 Cr., marking a decrease of 0.31 Cr..
- For Tax %, as of Dec 2025, the value is 50.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.29% (Sep 2025) to 50.00%, marking an increase of 26.71%.
- For Net Profit, as of Dec 2025, the value is 0.22 Cr.. The value appears to be declining and may need further review. It has decreased from 0.57 Cr. (Sep 2025) to 0.22 Cr., marking a decrease of 0.35 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.24. The value appears to be declining and may need further review. It has decreased from 0.62 (Sep 2025) to 0.24, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.54 | 0.66 | 0.64 | 1.11 | 1.06 | 0.88 | 0.59 | 1.24 | 3.70 | 1.83 | 9.25 | 8.78 | 10.31 |
| Expenses | 0.53 | 0.57 | 0.78 | 0.65 | 0.56 | 1.55 | 1.16 | 0.42 | 0.61 | 4.14 | 7.61 | 6.85 | 8.09 |
| Operating Profit | 0.01 | 0.09 | -0.14 | 0.46 | 0.50 | -0.67 | -0.57 | 0.82 | 3.09 | -2.31 | 1.64 | 1.93 | 2.22 |
| OPM % | 1.85% | 13.64% | -21.88% | 41.44% | 47.17% | -76.14% | -96.61% | 66.13% | 83.51% | -126.23% | 17.73% | 21.98% | 21.53% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.36 | 0.00 | 0.00 | 0.01 | 0.03 | 0.00 | 0.15 | 0.37 | 0.31 | 0.31 |
| Interest | 0.03 | 0.02 | 0.00 | 0.00 | 0.03 | 0.04 | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | 0.08 | 0.40 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.07 | 0.08 | 0.06 | 0.05 | 0.06 |
| Profit before tax | -0.04 | 0.05 | -0.16 | 0.80 | 0.45 | -0.72 | -0.60 | 0.82 | 3.02 | -2.25 | 1.95 | 2.11 | 2.07 |
| Tax % | 25.00% | 60.00% | 0.00% | 10.00% | 20.00% | -22.22% | 0.00% | 48.78% | 18.87% | -32.89% | 10.26% | 35.07% | |
| Net Profit | -0.05 | 0.02 | -0.16 | 0.71 | 0.36 | -0.55 | -0.60 | 0.42 | 2.45 | -1.52 | 1.75 | 1.38 | 1.34 |
| EPS in Rs | -0.05 | 0.02 | -0.17 | 0.77 | 0.39 | -0.60 | -0.65 | 0.46 | 2.66 | -1.65 | 1.90 | 1.51 | 1.46 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 140.00% | -900.00% | 543.75% | -49.30% | -252.78% | -9.09% | 170.00% | 483.33% | -162.04% | 215.13% | -21.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1040.00% | 1443.75% | -593.05% | -203.48% | 243.69% | 179.09% | 313.33% | -645.37% | 377.17% | -236.27% |
Moongipa Capital Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 72% |
| 3 Years: | 33% |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 34% |
| 3 Years: | -17% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 62% |
| 3 Years: | 9% |
| 1 Year: | -42% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 13% |
| 3 Years: | 6% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: February 1, 2026, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 3.05 | 9.16 | 9.16 |
| Reserves | 0.50 | 0.51 | 0.35 | 1.06 | 1.42 | 0.87 | 0.26 | 0.68 | 3.13 | 1.61 | 3.35 | 13.70 | 15.21 |
| Borrowing | 0.26 | 0.05 | 0.40 | 0.25 | 0.61 | 0.31 | 0.31 | 0.00 | 0.00 | 0.12 | 0.00 | 7.01 | 7.45 |
| Other Liabilities | 0.04 | 0.03 | 0.02 | 0.08 | 0.03 | 0.06 | 0.05 | 0.21 | 0.78 | 0.06 | 0.20 | 0.67 | 0.82 |
| Total Liabilities | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 | 32.64 |
| Fixed Assets | 0.07 | 0.04 | 0.07 | 0.05 | 0.04 | 0.03 | 0.07 | 0.05 | 0.31 | 0.23 | 0.18 | 0.13 | 0.20 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.88 | 0.93 | 1.33 | 1.47 | 1.65 | 0.96 | 1.60 | 2.58 | 5.34 | 2.64 | 1.43 | 6.85 | 6.57 |
| Other Assets | 2.90 | 2.67 | 2.42 | 2.92 | 3.42 | 3.30 | 2.00 | 1.31 | 1.31 | 1.97 | 4.99 | 23.56 | 25.87 |
| Total Assets | 3.85 | 3.64 | 3.82 | 4.44 | 5.11 | 4.29 | 3.67 | 3.94 | 6.96 | 4.84 | 6.60 | 30.54 | 32.64 |
Below is a detailed analysis of the balance sheet data for Moongipa Capital Finance Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.16 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.16 Cr..
- For Reserves, as of Sep 2025, the value is 15.21 Cr.. The value appears strong and on an upward trend. It has increased from 13.70 Cr. (Mar 2025) to 15.21 Cr., marking an increase of 1.51 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.67 Cr. (Mar 2025) to 0.82 Cr., marking an increase of 0.15 Cr..
- For Total Liabilities, as of Sep 2025, the value is 32.64 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.54 Cr. (Mar 2025) to 32.64 Cr., marking an increase of 2.10 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.07 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 6.57 Cr.. The value appears to be declining and may need further review. It has decreased from 6.85 Cr. (Mar 2025) to 6.57 Cr., marking a decrease of 0.28 Cr..
- For Other Assets, as of Sep 2025, the value is 25.87 Cr.. The value appears strong and on an upward trend. It has increased from 23.56 Cr. (Mar 2025) to 25.87 Cr., marking an increase of 2.31 Cr..
- For Total Assets, as of Sep 2025, the value is 32.64 Cr.. The value appears strong and on an upward trend. It has increased from 30.54 Cr. (Mar 2025) to 32.64 Cr., marking an increase of 2.10 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.25 | 0.04 | -0.54 | 0.21 | -0.11 | -0.98 | -0.88 | 0.82 | 3.09 | -2.43 | 1.64 | -5.08 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.96 | 7.10 | 50.72 |
| Inventory Days | 463.06 | 199.54 | 430.81 | |||||||||
| Days Payable | 0.00 | 0.00 | 0.00 | |||||||||
| Cash Conversion Cycle | 1,013.89 | 1,249.85 | 216.72 | 85.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 477.02 | 206.64 | 481.53 |
| Working Capital Days | 919.26 | 1,227.73 | 39.92 | 62.48 | 134.29 | 825.40 | 532.03 | 158.95 | 53.27 | 295.19 | 177.96 | 875.92 |
| ROCE % | -0.26% | 1.89% | -4.32% | 19.61% | 10.17% | -14.61% | -15.03% | 22.59% | 60.95% | -40.88% | 34.88% | 12.08% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
| Diluted EPS (Rs.) | 3.01 | 5.71 | -4.98 | 8.01 | 1.36 |
| Cash EPS (Rs.) | 1.55 | 5.91 | -4.71 | 8.23 | 1.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 24.94 | 20.97 | 15.26 | 20.23 | 12.23 |
| Revenue From Operations / Share (Rs.) | 9.56 | 30.28 | 5.98 | 10.45 | 3.22 |
| PBDIT / Share (Rs.) | 2.44 | 6.59 | -7.09 | 10.11 | 2.78 |
| PBIT / Share (Rs.) | 2.39 | 6.38 | -7.36 | 9.89 | 2.71 |
| PBT / Share (Rs.) | 2.30 | 6.38 | -7.39 | 9.88 | 2.68 |
| Net Profit / Share (Rs.) | 1.50 | 5.71 | -4.98 | 8.01 | 1.36 |
| PBDIT Margin (%) | 25.52 | 21.75 | -118.56 | 96.75 | 86.25 |
| PBIT Margin (%) | 24.96 | 21.08 | -123.04 | 94.61 | 84.15 |
| PBT Margin (%) | 24.10 | 21.07 | -123.44 | 94.55 | 83.13 |
| Net Profit Margin (%) | 15.71 | 18.86 | -83.15 | 76.61 | 42.29 |
| Return on Networth / Equity (%) | 6.02 | 27.23 | -32.61 | 39.56 | 11.14 |
| Return on Capital Employeed (%) | 9.32 | 29.77 | -48.15 | 43.60 | 21.19 |
| Return On Assets (%) | 4.50 | 26.44 | -31.41 | 35.12 | 10.56 |
| Total Debt / Equity (X) | 0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.47 | 1.62 | 0.30 | 0.58 | 0.25 |
| Current Ratio (X) | 4.29 | 137.98 | 27.37 | 189.17 | 118.77 |
| Quick Ratio (X) | 3.29 | 59.81 | 22.32 | 189.17 | 118.77 |
| Inventory Turnover Ratio (X) | 1.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 29.55 | 1770.36 | -298.50 | 1674.16 | 83.93 |
| Interest Coverage Ratio (Post Tax) (X) | 19.19 | 1536.47 | -208.36 | 1326.56 | 42.16 |
| Enterprise Value (Cr.) | 24.69 | 8.89 | 5.21 | 6.73 | 0.91 |
| EV / Net Operating Revenue (X) | 2.82 | 0.96 | 2.85 | 2.11 | 0.92 |
| EV / EBITDA (X) | 11.04 | 4.42 | -2.40 | 2.18 | 1.08 |
| MarketCap / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
| Price / BV (X) | 0.77 | 1.40 | 1.12 | 1.11 | 0.28 |
| Price / Net Operating Revenue (X) | 2.02 | 0.96 | 2.86 | 2.14 | 1.07 |
| EarningsYield | 0.07 | 0.19 | -0.29 | 0.35 | 0.39 |
After reviewing the key financial ratios for Moongipa Capital Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.01. This value is below the healthy minimum of 5. It has decreased from 5.71 (Mar 24) to 3.01, marking a decrease of 2.70.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 3. It has decreased from 5.91 (Mar 24) to 1.55, marking a decrease of 4.36.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 24.94. It has increased from 20.97 (Mar 24) to 24.94, marking an increase of 3.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.56. It has decreased from 30.28 (Mar 24) to 9.56, marking a decrease of 20.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 2.44, marking a decrease of 4.15.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.39, marking a decrease of 3.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 6.38 (Mar 24) to 2.30, marking a decrease of 4.08.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.50. This value is below the healthy minimum of 2. It has decreased from 5.71 (Mar 24) to 1.50, marking a decrease of 4.21.
- For PBDIT Margin (%), as of Mar 25, the value is 25.52. This value is within the healthy range. It has increased from 21.75 (Mar 24) to 25.52, marking an increase of 3.77.
- For PBIT Margin (%), as of Mar 25, the value is 24.96. This value exceeds the healthy maximum of 20. It has increased from 21.08 (Mar 24) to 24.96, marking an increase of 3.88.
- For PBT Margin (%), as of Mar 25, the value is 24.10. This value is within the healthy range. It has increased from 21.07 (Mar 24) to 24.10, marking an increase of 3.03.
- For Net Profit Margin (%), as of Mar 25, the value is 15.71. This value exceeds the healthy maximum of 10. It has decreased from 18.86 (Mar 24) to 15.71, marking a decrease of 3.15.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.02. This value is below the healthy minimum of 15. It has decreased from 27.23 (Mar 24) to 6.02, marking a decrease of 21.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.32. This value is below the healthy minimum of 10. It has decreased from 29.77 (Mar 24) to 9.32, marking a decrease of 20.45.
- For Return On Assets (%), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. It has decreased from 26.44 (Mar 24) to 4.50, marking a decrease of 21.94.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.30. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.30, marking an increase of 0.30.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 1.62 (Mar 24) to 0.47, marking a decrease of 1.15.
- For Current Ratio (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 137.98 (Mar 24) to 4.29, marking a decrease of 133.69.
- For Quick Ratio (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 2. It has decreased from 59.81 (Mar 24) to 3.29, marking a decrease of 56.52.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 1.64, marking an increase of 1.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 29.55. This value is within the healthy range. It has decreased from 1,770.36 (Mar 24) to 29.55, marking a decrease of 1,740.81.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 19.19. This value is within the healthy range. It has decreased from 1,536.47 (Mar 24) to 19.19, marking a decrease of 1,517.28.
- For Enterprise Value (Cr.), as of Mar 25, the value is 24.69. It has increased from 8.89 (Mar 24) to 24.69, marking an increase of 15.80.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.82, marking an increase of 1.86.
- For EV / EBITDA (X), as of Mar 25, the value is 11.04. This value is within the healthy range. It has increased from 4.42 (Mar 24) to 11.04, marking an increase of 6.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For Price / BV (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.77, marking a decrease of 0.63.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has increased from 0.96 (Mar 24) to 2.02, marking an increase of 1.06.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has decreased from 0.19 (Mar 24) to 0.07, marking a decrease of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Moongipa Capital Finance Ltd:
- Net Profit Margin: 15.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.32% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.02% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 19.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.29
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.8 (Industry average Stock P/E: 71.1)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.3
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 18/14, W.E.A. Pusa Lane, Karol Bagh, New Delhi Delhi 110005 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr.(Ms.) Pooja Jain | Whole Time Director |
| Mr. Sanjay Jain | Non Executive Director |
| Mr. Ajay Prakash Narain | Independent Director |
| Mr. Rajesh Kumar | Independent Director |
FAQ
What is the intrinsic value of Moongipa Capital Finance Ltd?
Moongipa Capital Finance Ltd's intrinsic value (as of 07 February 2026) is ₹21.42 which is 37.31% higher the current market price of ₹15.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹14.3 Cr. market cap, FY2025-2026 high/low of ₹24.7/14.8, reserves of ₹15.21 Cr, and liabilities of ₹32.64 Cr.
What is the Market Cap of Moongipa Capital Finance Ltd?
The Market Cap of Moongipa Capital Finance Ltd is 14.3 Cr..
What is the current Stock Price of Moongipa Capital Finance Ltd as on 07 February 2026?
The current stock price of Moongipa Capital Finance Ltd as on 07 February 2026 is ₹15.6.
What is the High / Low of Moongipa Capital Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Moongipa Capital Finance Ltd stocks is ₹24.7/14.8.
What is the Stock P/E of Moongipa Capital Finance Ltd?
The Stock P/E of Moongipa Capital Finance Ltd is 11.8.
What is the Book Value of Moongipa Capital Finance Ltd?
The Book Value of Moongipa Capital Finance Ltd is 26.6.
What is the Dividend Yield of Moongipa Capital Finance Ltd?
The Dividend Yield of Moongipa Capital Finance Ltd is 0.00 %.
What is the ROCE of Moongipa Capital Finance Ltd?
The ROCE of Moongipa Capital Finance Ltd is 12.1 %.
What is the ROE of Moongipa Capital Finance Ltd?
The ROE of Moongipa Capital Finance Ltd is 9.43 %.
What is the Face Value of Moongipa Capital Finance Ltd?
The Face Value of Moongipa Capital Finance Ltd is 10.0.